Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. | 30177781 | Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, Wactawski-Wende J, Van Dyke AL, Stampfer MJ, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Purdue MP, Poynter JN, Palmer JR, Newton CC, Linet MS, Liao LM, Lee IM, Koshiol J, K… | Am J Gastroenterol | 2018 | PLCO |
| Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. | 29520041 | Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, Buring JE, Chan AT, Chong DQ, Doody MM, Gapstur SM, Gaziano JM, Giovannucci E, Graubard BI, Lee IM, Liao LM, Linet MS, Palmer JR, Poynter JN, Purdue MP, Robien K, Rosenbe… | Br J Cancer | 2018 | PLCO |
| Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial. | 30199643 | Iaccarino JM, Steiling KA, Wiener RS | Ann Am Thorac Soc | 2018 | NLST |
| Automatic segmentation of thoracic aorta segments in low-dose chest CT | Julia M. H. Noothout, Bob D. de Vos, Jelmer M. Wolterink, Ivana Išgum | Medical Imaging 2018 | 2018 | NLST | |
| Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia. | 29689434 | Wade S, Weber M, Caruana M, Kang YJ, Marshall H, Manser R, Vinod S, Rankin N, Fong K, Canfell K | J Thorac Oncol | 2018 | NLST |
| A multi-parameterized artificial neural network for lung cancer risk prediction. | 30356283 | Hart GR, Roffman DA, Decker R, Deng J | PLoS One | 2018 | PLCO |
| Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network. | 29374196 | Roffman D, Hart G, Girardi M, Ko CJ, Deng J | Sci Rep | 2018 | PLCO |
| Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies. | 29582567 | Chong DQ, Banbury BL, Phipps AI, Hua X, Kocarnik J, Peters U, Berndt SI, Huang WY, Potter JD, Slattery ML, White E, Campbell PT, Harrison T, Newcomb PA, Chan AT | Cancer Med | 2018 | PLCO |
| Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial | Jason Y Y Wong, Bryan A Bassig, Wei Jie Seow, Wei Hu, Bu-Tian Ji, Aaron Blair, Debra T Silverman, Qing Lan | Occup Environ Med | 2017 | NLST | |
| Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. | 28050695 | Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR | Eur Radiol | 2017 | NLST |
| Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? | 27837443 | Hawkins ML, Buys SS, Gren LH, Simonsen SE, Kirchhoff AC, Hashibe M | J Cancer Surviv | 2017 | PLCO |
| Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men. | 27480499 | Stone BV, Shoag J, Halpern JA, Mittal S, Lewicki P, Golombos DM, Bedretdinova D, Chughtai B, Barbieri CE, Lee RK | BJU Int. | 2017 | PLCO |
| Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. | 27911486 | Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED, Grubb RL, Andriole GL | Cancer | 2017 | PLCO |
| Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer. | 27699819 | Shoaibi A, Rao GA, Cai B, Rawl J, Haddock KS, Hébert JR | Prostate | 2017 | PLCO |
| Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm. | 27569432 | Halpern JA, Shoag JE, Mittal S, Oromendia C, Ballman KV, Hershman DL, Wright JD, Shih YT, Nguyen PL, Hu JC | J. Urol. | 2017 | PLCO |
| Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. | 27770434 | Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N | Int. J. Cancer | 2017 | PLCO |
| Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial. | 27754927 | Kelly SP, Graubard BI, Andreotti G, Younes N, Cleary SD, Cook MB | J. Natl. Cancer Inst. | 2017 | PLCO |
| Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. | 28510291 | Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q | Int. J. Cancer | 2017 | PLCO |
| Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. | 28484923 | Liao LM, Hofmann JN, Cho E, Pollak MN, Chow WH, Purdue MP | Cancer Causes Control | 2017 | PLCO |
| Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts. | 28507039 | Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB | Cancer Prev Res (Phila) | 2017 | PLCO |